DROR Dror Ortho-Design, Inc.
Dental Equipment & Supplies · OTC · SEC CIK 1282980 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY25.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-852.0%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets1,702.6%
Debt / equity—
Current ratio0.06x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.73x
Accruals ratio-225.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | $2,568 |
| R&D expense | $815,902 | $1.54M | $1.06M | $850,680 | — |
| SG&A expense | $1.37M | $1.44M | $1.06M | $814,653 | $97,464 |
| Operating income | -$2.22M | -$5.22M | -$4.38M | -$1.69M | -$170,302 |
| Interest expense | — | — | — | $14 | $207 |
| Pretax income | -$2.54M | -$5.78M | -$3.57M | -$1.68M | -$170,509 |
| Net income | -$2.54M | -$5.78M | -$3.57M | -$1.68M | -$170,509 |
| EBITDA | -$2.22M | -$5.22M | -$4.38M | -$1.68M | — |
| EPS (basic) | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 957.00M | 672.51M | 296.66M | 437.74M | 202.31M |
| Balance sheet | |||||
| Cash & equivalents | $228,540 | $549,444 | $3.35M | $1.04M | $2.56M |
| Receivables | — | — | — | — | $1,360 |
| Current assets | $238,774 | $638,583 | $3.46M | $1.14M | $192,363 |
| PP&E, net | $20,162 | $24,142 | $2,328 | $2,998 | — |
| Total assets | $258,936 | $662,725 | $3.46M | $1.14M | $192,363 |
| Current liabilities | $2.96M | $906,738 | $297,104 | $546,918 | $737,469 |
| Total liabilities | $3.13M | $1.03M | $302,347 | $547,334 | $737,469 |
| Shareholders' equity | -$2.87M | -$367,994 | $3.16M | $596,076 | $2.26M |
| Shares outstanding | 957.00M | 957.00M | 495.45M | 437.74M | 202.31M |
| Cash flow statement | |||||
| Operating cash flow | -$2.06M | -$2.74M | -$2.39M | -$1.52M | -$136,097 |
| Capital expenditure | $966 | $25,849 | — | — | — |
| Free cash flow | -$2.06M | -$2.77M | — | — | — |
| Investing cash flow | -$966 | -$25,849 | $17,966 | — | — |
| Financing cash flow | $1.75M | — | $4.65M | — | — |
| Depreciation & amortization | $4,946 | $4,035 | $670 | $670 | — |
| Stock-based compensation | $39,170 | $2.25M | $2.25M | $19,908 | — |
Free plan shows the latest 5 periods; Pro shows all 8 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.